Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more

by | Mar 10, 2026 | Financial

Check out some of the companies making the biggest moves midday: Hims & Hers Health — Shares of the telehealth company jumped 3%. Bank of America upgraded the stock to neutral from underperform after Novo Nordisk dropped its patent infringement case against Hims, and the companies agreed that Hims would sell Novo’s Ozempic and Wegovy drugs on its platform. Novo’s move to drop the case is “a clear positive in our view as it removes litigation and related credit risk — the primary driver of the new and higher multiple in our model,” wrote analyst Allen Lutz in a Tuesday note. BioNTech — U.S.-traded shares of the German biotech company cratered more than 20%. BioNTech announced that its co-founders, Drs. Ugur Sahin and Özlem Türeci, would leave to establish and lead an independent company. Separately, BioNTech reported a fourth-quarter net loss of 305 million euros ($355.75 million). SolarEdge Technologies — The solar stock surged nearly 10% after Bank of America upgraded it to neutral from underperform. The Wall Street firm said SolarEdge’s margin trajectory, revenue cadence and liquidity have all stabilized enough to materially reduce downside risk. West Pharmaceutical Services — The drugmaker fell 6% after it said CEO and chairman Eric Green will retire in the second half of 2026. United Natural Foods — Shares lost almost 3%. The grocery distributor reported revenue of $7.95 billion in its fis …

Article Attribution | Read More at Article Source